Europe Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Europe Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Europe Cell and Gene Therapy Manufacturing QC Market was valued at USD 420.3 Million in 2024 and is projected to reach USD 1031.59 Million by 2028, expanding at a CAGR of 25.2% during the forecast period. The primary industries driving demand in this market include healthcare, biotechnology, and pharmaceuticals. Key market drivers come from precision medicine, cancer treatments, and advancements in gene editing technologies like CRISPR. The rising prevalence of genetic disorders is spurring market demand too. Emerging trends include leveraging AI for efficient quality control and low-carbon production techniques supporting sustainability. As Europe spearheads novel gene therapy research and navigates stringent quality controls, it will fortify its position in the global cell and gene therapy manufacturing QC market in coming years.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market Highlights
- Cell Therapy represented the largest share of the Therapy Type market in terms of size in 2024.
- Among the Therapy Type segments, Gene Therapy is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.
- In 2024, Europe accounted for 18.8% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is projected to lead the global market in terms of market size.
- France is projected to emerge as the fastest-growing market in Europe, reaching USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 420.3 Million |
| Market Size In 2028 | USD 1031.59 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 25.2% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Europe Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Europe Cell and Gene Therapy Manufacturing QC Market By Country 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
